MedTrace Logo

The Prospective Cohort Study on the Benefit-risk of Antithrombotic or Anticoagulant Therapy in Patients With Unruptured Intracranial Aneurysms Associated With Ischemic Heart Disease or Ischemic Cerebrovascular Disease

NCT03153878 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1800

Last updated 2017-05-15

No results posted yet for this study

Summary

This is a registry study of the natural course of unruptured intracranial aneurysms (UIA). In addition, the investigators will analyze the benefit-risk of antithrombotic or anticoagulant therapy in patients with unruptured intracranial aneurysms associated with ischemic heart disease or ischemic cerebrovascular disease. The investigators aim to use research data to create a China national database of UIA

Conditions

  • Intracranial Aneurysm
  • Natural History
  • Ischemic Heart Disease
  • Ischemic Cerebrovascular Disease

Sponsors & Collaborators

  • Xuanwu Hospital, Beijing

    collaborator OTHER

  • Liu Zhiyong

    lead OTHER

Principal Investigators

  • Min He, M.D. · West China Hospital

Eligibility

Min Age
14 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-06-01
Primary Completion
2020-12-31
Completion
2021-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03153878 on ClinicalTrials.gov